Livforsakringsbolaget Skandia’s Bio-Techne TECH Stock Holding History

Livforsakringsbolaget Skandia’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-878	Closed	-$51.5K	–	570
2025 Q1	$51.5K	Hold	878	–	–	﹤0.01%	539
2024 Q4	$63.2K	Sell	878 -500	-36%	-$36.7K	﹤0.01%	528
2024 Q3	$110K	Buy	1,378 +1,200	+674%	+$90.2K	0.01%	509
2024 Q2	$12.7K	Hold	178	–	–	﹤0.01%	526
2024 Q1	$12.5K	Hold	178	–	–	﹤0.01%	540
2023 Q4	$13.7K	Hold	178	–	–	﹤0.01%	534
2023 Q3	$12.1K	Hold	178	–	–	﹤0.01%	523
2023 Q2	$14.5K	Hold	178	–	–	﹤0.01%	514
2023 Q1	$13.2K	Hold	178	–	–	﹤0.01%	528
2022 Q4	$14.7K	Buy	+178	New	+$14.1K	﹤0.01%	497
2022 Q3	–	Sell	-800	Closed	-$69K	–	600
2022 Q2	$69K	Sell	800 -400	-33%	-$37.5K	0.01%	511
2022 Q1	$130K	Buy	+1,200	New	+$124K	0.01%	535

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Livforsakringsbolaget Skandia's TECH Position: Q2 2025 in Review

Livforsakringsbolaget Skandia sold out of Bio-Techne (TECH) in Q2 2025, closing a stake of 878 shares — an estimated $51.5K sold.

Livforsakringsbolaget Skandia first reported a position in TECH in Q1 2022 and held it in 12 quarters. The position peaked at $130K in Q1 2022. 556 funds tracked by Wall St. Rank hold TECH as of Q2 2025.

Livforsakringsbolaget Skandia reported no remaining Bio-Techne position as of Q2 2025 after selling out during the quarter.
Livforsakringsbolaget Skandia sold 878 Bio-Techne shares in Q2 2025, an estimated $51.5K.
Livforsakringsbolaget Skandia first reported a position in Bio-Techne in Q1 2022 and held it in 12 quarters.
Livforsakringsbolaget Skandia's Bio-Techne position peaked at $130K in Q1 2022.
556 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2025.

Based on Livforsakringsbolaget Skandia's 13F filing for Q2 2025, filed 9 Jul 2025.